These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15527257)

  • 1. Stereoselective photochemical 1,3-dioxolane addition to 5-alkoxymethyl-2(5H)-furanone: synthesis of bis-tetrahydrofuranyl ligand for HIV protease inhibitor UIC-94017 (TMC-114).
    Ghosh AK; Leshchenko S; Noetzel M
    J Org Chem; 2004 Nov; 69(23):7822-9. PubMed ID: 15527257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective and efficient synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol.
    Quaedflieg PJ; Kesteleyn BR; Wigerinck PB; Goyvaerts NM; Vijn RJ; Liebregts CS; Kooistra JH; Cusan C
    Org Lett; 2005 Dec; 7(26):5917-20. PubMed ID: 16354099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
    Ghosh AK; Swanson LM; Cho H; Leshchenko S; Hussain KA; Kay S; Walters DE; Koh Y; Mitsuya H
    J Med Chem; 2005 May; 48(10):3576-85. PubMed ID: 15887965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.
    Ghosh AK; Kincaid JF; Walters DE; Chen Y; Chaudhuri NC; Thompson WJ; Culberson C; Fitzgerald PM; Lee HY; McKee SP; Munson PM; Duong TT; Darke PL; Zugay JA; Schleif WA; Axel MG; Lin J; Huff JR
    J Med Chem; 1996 Aug; 39(17):3278-90. PubMed ID: 8765511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disubstituted Bis-THF Moieties as New P2 Ligands in Nonpeptidal HIV-1 Protease Inhibitors (II).
    Hohlfeld K; Wegner JK; Kesteleyn B; Linclau B; Unge J
    J Med Chem; 2015 May; 58(9):4029-38. PubMed ID: 25897791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric One-Pot Synthesis of (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol: A Key Component of Current HIV Protease Inhibitors.
    Sevenich A; Liu GQ; Arduengo AJ; Gupton BF; Opatz T
    J Org Chem; 2017 Jan; 82(2):1218-1223. PubMed ID: 27997193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Chiron Approach to (3
    Ghosh AK; Markad SB; Robinson WL
    J Org Chem; 2021 Jan; 86(1):1216-1222. PubMed ID: 33267583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of novel HIV-1 protease inhibitors to combat drug resistance.
    Ghosh AK; Sridhar PR; Leshchenko S; Hussain AK; Li J; Kovalevsky AY; Walters DE; Wedekind JE; Grum-Tokars V; Das D; Koh Y; Maeda K; Gatanaga H; Weber IT; Mitsuya H
    J Med Chem; 2006 Aug; 49(17):5252-61. PubMed ID: 16913714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.
    Ghosh AK; Chapsal BD; Weber IT; Mitsuya H
    Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Photochemical Route to Optically Active Hexahydro-4
    Ghosh AK; Robinson WL
    J Org Chem; 2019 Aug; 84(15):9801-9805. PubMed ID: 31310117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of gem-difluoro-bis-tetrahydrofuran as P2 ligand for HIV-1 protease inhibitors to improve brain penetration: synthesis, X-ray studies, and biological evaluation.
    Ghosh AK; Yashchuk S; Mizuno A; Chakraborty N; Agniswamy J; Wang YF; Aoki M; Gomez PM; Amano M; Weber IT; Mitsuya H
    ChemMedChem; 2015 Jan; 10(1):107-15. PubMed ID: 25336073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-acyl aromatic alpha-amino acids.
    Stranix BR; Lavallée JF; Sévigny G; Yelle J; Perron V; LeBerre N; Herbart D; Wu JJ
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3459-62. PubMed ID: 16644213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.
    Ali A; Reddy GS; Cao H; Anjum SG; Nalam MN; Schiffer CA; Rana TM
    J Med Chem; 2006 Dec; 49(25):7342-56. PubMed ID: 17149864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient synthesis of (3R,3aS,6aR)- hexahydrofuro[2,3-b]furan-3-ol from glycolaldehyde.
    Canoy WL; Cooley BE; Corona JA; Lovelace TC; Millar A; Weber AM; Xie S; Zhang Y
    Org Lett; 2008 Mar; 10(6):1103-6. PubMed ID: 18290653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potent human immunodeficiency virus type 1 protease inhibitor, UIC-94003 (TMC-126), and selection of a novel (A28S) mutation in the protease active site.
    Yoshimura K; Kato R; Kavlick MF; Nguyen A; Maroun V; Maeda K; Hussain KA; Ghosh AK; Gulnik SV; Erickson JW; Mitsuya H
    J Virol; 2002 Feb; 76(3):1349-58. PubMed ID: 11773409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent HIV-1 protease inhibitors incorporating hexahydrofuropyranol-derived high affinity P(2) ligands: structure-activity studies and biological evaluation.
    Ghosh AK; Chapsal BD; Baldridge A; Steffey MP; Walters DE; Koh Y; Amano M; Mitsuya H
    J Med Chem; 2011 Jan; 54(2):622-34. PubMed ID: 21194227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-peptidic HIV protease inhibitors: C2-symmetry-based design of bis-sulfonamide dihydropyrones.
    Janakiraman MN; Watenpaugh KD; Tomich PK; Chong KT; Turner SR; Tommasi RA; Thaisrivongs S; Strohbach JW
    Bioorg Med Chem Lett; 1998 May; 8(10):1237-42. PubMed ID: 9871742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chiral-catalyst-based convergent synthesis of HIV protease inhibitor GRL-06579A.
    Mihara H; Sohtome Y; Matsunaga S; Shibasaki M
    Chem Asian J; 2008 Feb; 3(2):359-66. PubMed ID: 18161742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands.
    Gao BL; Zhang CM; Yin YZ; Tang LQ; Liu ZP
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3730-3. PubMed ID: 21555220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymmetric synthesis of the potent HIV-protease inhibitor, nelfinavir.
    Raghavan S; Krishnaiah V; Sridhar B
    J Org Chem; 2010 Jan; 75(2):498-501. PubMed ID: 20000659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.